Recurrence of Scedosporium apiospermum infection following renal re-transplantation

被引:18
作者
Ahmed, J [1 ]
Ditmars, DM
Sheppard, T
del Busto, R
Venkat, KK
Parasuraman, R
机构
[1] Henry Ford Hosp, Div Nephrol, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Div Plast Surg, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Div Infect Dis, Detroit, MI 48202 USA
关键词
Scedosporium apiospermum; kidney transplant;
D O I
10.1111/j.1600-6143.2004.00576.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Immunosuppression for organ transplantation results in increased susceptibility to opportunistic infections including fungal, such as Scedosporium apiospermum. Even though many reported cases of this infection had both local and systemic manifestations, majority of the systemic infections had a fatal outcome. We report a case of a 50-year-old Caucasian male with lymphocutaneous and presumed pulmonary Scedosporium infection 4 years after renal transplantation that was successfully treated with voriconazole and discontinuation of immunosuppression. He received a second transplant 3 years later in the absence of clinical evidence of S. apiospermum infection. Unfortunately, 4 months after transplantation he developed recurrence of the same infection localizing to the soft tissues. Presently this infection is under control with surgical excision and voriconazole therapy. To our knowledge this is the first reported case of recurrent S.apiospermum infection in a renal transplant recipient. We suggest prophylactic antifungal therapy in all re-transplants with this infection.
引用
收藏
页码:1720 / 1724
页数:5
相关论文
共 20 条
  • [1] Lung scedosporiosis:: a differential diagnosis of aspergillosis
    Al Refaï, M
    Duhamel, C
    Le Rochais, JP
    Icard, P
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (05) : 938 - 939
  • [2] Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy
    Baden, LR
    Katz, JT
    Fishman, JA
    Koziol, C
    DelVecchio, A
    Doran, M
    Rubin, RH
    [J]. TRANSPLANTATION, 2003, 76 (11) : 1632 - 1637
  • [3] Lymphocutaneous syndrome due to Scedosporium apiospermum
    Canet, JJ
    Pagerols, X
    Sánchez, C
    Vives, P
    Garau, J
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (11) : 648 - 650
  • [4] Pseudallescheria boydii (anamorph Scedosporium apiospermum) infection in solid organ transplant recipients in a tertiary medical center and review of the literature
    Castiglioni, B
    Sutton, DA
    Rinaldi, MG
    Fung, J
    Kusne, S
    [J]. MEDICINE, 2002, 81 (05) : 333 - 348
  • [5] Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
    Cuenca-Estrella, M
    Ruiz-Díez, B
    Martínez-Suárez, JV
    Monzón, A
    Rodríguez-Tudela, JL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) : 149 - 151
  • [6] Voriconazole in the treatment of invasive mold infections in transplant recipients
    Fortún, J
    Martín-Dávila, P
    Sánchez, MA
    Pintado, V
    Alvarez, ME
    Sánchez-Sousa, A
    Moreno, S
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (07) : 408 - 413
  • [7] Kusne S, 2000, Transpl Infect Dis, V2, P194, DOI 10.1034/j.1399-3062.2000.020405.x
  • [8] In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates
    Meletiadis, J
    Meis, JFGM
    Mouton, JW
    Rodriquez-Tudela, JL
    Donnelly, JP
    Verweij, PE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 62 - 68
  • [9] Treatment of Scedosporium apiospermum brain abscesses with posaconazole
    Mellinghoff, IK
    Winston, DJ
    Mukwaya, G
    Schiller, GJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) : 1648 - 1650
  • [10] Scedosporium apiospermum skin infection:: A case report and review of the literature
    Miyamoto, T
    Sasaoka, R
    Kawaguchi, M
    Ishioka, S
    Inoue, T
    Yamada, N
    Mihara, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (03) : 498 - 500